Aurobindo Pharma Ltd gets Form 483 with 4 observations from USFDA for inspection at Unit XIV

The United States Food and Drug Administration (US FDA) inspected Aurobindo Pharma Ltd's Unit XIV, an API Non antibiotic Manufacturing facility situated at Paravada Industrial Area, Anakapalli District. Andhra Pradesh, from 15th May to 19th May 2023. At the end of the inspection, we have been issued a 'Form 483' with Four observations. The observations are procedural in nature. We will respond to the US FDA within the stipulated timelines and work closely with US FDA to close the observations at the earliest.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 589.45 as compared to the previous close of Rs. 599.30. The total number of shares traded during the day was 46029 in over 1969 trades.

The stock hit an intraday high of Rs. 606.55 and intraday low of 581.50. The net turnover during the day was Rs. 27242435.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 USFDA Inspection Form483 4Observations